Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial
This study was funded by the National Institutes of Health, National Cancer Institute grant R01CA214890.
Authors
- Barbara L. Averill
- Francisco Vega (ORCID: https://orcid.org/0000-0001-5956-452X)
- Jonathon Brett Cohen (ORCID: https://orcid.org/0000-0002-2723-6481)
- Loretta J. Nastoupil (ORCID: https://orcid.org/0000-0001-6071-8610)
- John P. Leonard (ORCID: https://orcid.org/0000-0002-5083-1115)
- Jonathan W. Friedberg (ORCID: https://orcid.org/0000-0002-1420-5563)
- Izidore S. Lossos (ORCID: https://orcid.org/0000-0002-9346-9013)
- Paul M. Barr (ORCID: https://orcid.org/0000-0002-9733-401X)
- Grerk Sutamtewagul (ORCID: https://orcid.org/0000-0002-1311-6227)
- Michael T. Brady (ORCID: https://orcid.org/0000-0002-0711-0435)
- Brad S. Kahl (ORCID: https://orcid.org/0000-0003-0459-6609)
- Myla Strawderman
- Andrea Baran (ORCID: https://orcid.org/0000-0002-7975-8919)
- Patrick M. Reagan (ORCID: https://orcid.org/0000-0002-7155-7063)
- John M. Ashton (ORCID: https://orcid.org/0000-0001-9875-5994)
- Carla Casulo (ORCID: https://orcid.org/0000-0001-9993-5065)
- Derick R. Peterson
- John Strang (ORCID: https://orcid.org/0000-0002-5993-388X)
Institutions
- NewYork–Presbyterian Hospital (US)
- The University of Texas MD Anderson Cancer Center (US)
- Emory University (US)
- Washington University in St. Louis (US)
- Cornell University (US)
- New York Hospital Queens (US)
- University of Iowa Hospitals and Clinics (US)
- Presbyterian Hospital (US)
- Sylvester Comprehensive Cancer Center (US)
- University of Rochester (US)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2024-11-27
- DOI
- https://doi.org/10.1016/j.eclinm.2024.102959
- Citations
- 5
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.12
Funders
- University of Rochester
- National Institutes of Health
- National Cancer Institute